MAGNETIC RESONANCE IMAGING IN DIAGNOSING FIBROTIC AND CICATRICIAL HEART ALTERATIONS IN CHILDREN
https://doi.org/10.15690/pf.v11i2.962
Abstract
The article provides an analysis of capabilities of magnetic resonance imaging with delayed contrast enhancement in diagnosing fibrotic alterations of varying severity. A hyperintense signal in the setting of myocardial delayed contrast enhancement programs indicates alterations of myocardial structure. Localization, severity and hyperintense signal size facilitate correct diagnosis and prognosis of complications development.
About the Authors
L. S. Namazova-BaranovaRussian Federation
V. I. Barskiy
Russian Federation
V. E. Sinitsyn
Russian Federation
E. N. Basargina
Russian Federation
A. N. Getman
Russian Federation
A. B. Sugak
Russian Federation
I. V. Silnova
Russian Federation
E. N. Arkhipova
Russian Federation
A. K. Gevorkyan
Russian Federation
References
1. Desjardins B., Crawford T., Good E., Oral H., Chugh A., Pelosi F., Morady F., Bogun F. Infarct architecture and characteristics on delayed enhanced magnetic resonance imaging and electroanatomic mapping in patients with post-infarction ventricular arrhythmia. Author manuscript; available in PMC 2010 May 1. Heart Rhythm. 2009 May; 6(5): 644–651.
2. Nathan M., Ying L. C., Pierre C., David B., Joao L. Assessment of myocardial fibrosis with cardiac magnetic resonance. Author manuscript; available in PMC 2012 February 22. J. Am. Coll. Cardiol. 2011 Feb. 22; 57(8): 891–903.
3. Florian A., Jurcut R., Ginghina C., Bogaert J. Cardiac Magnetic Resonance Imaging in Ischemic Heart Disease: A Clinical Review. J. Med. Life. 2011 Nov. 14; 4(4): 330–345. Published online 2011 Nov. 24.
4. Edelman R., Hesselink J., Zlatkin M. Clinical magnetic resonance imaging. 3rd Ed. Philadelphia, W.B. Saunders Co, 2004.
5. Parsai C., O’Hanlon R., Prasad S. K., Mohiaddin R. H. Diagnostic and prognostic value of cardiovascular magnetic resonance in nonischaemic cardiomyopathies. J Cardiovasc Magn Reson. 2012; 14(1): 54. Published online 2012 Aug. 2.
6. Adabag A. S., Maron B. J., Appelbaum E. et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 2008; 51: 1369–1374.
7. O'Hanlon R., Grasso A., Roughton M., Moon J. C., Clark S., Wage R., Webb J., Kulkarni M., Dawson D., Sulaibeekh L., Chandrasekaran B., Bucciarelli-Ducci C., Pasquale F., Cowie M. R., McKenna W. J., Sheppard M. N., Elliott P. M., Pennell D. J., Prasad S. K. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2010 Sep. 7; 56(11): 867–874.
8. Bruder O., Wagner A., Jensen C. J., Schneider S., Ong P., Kispert E. M., Nassenstein K., Schlosser T., Sabin G. V., Sechtem U., Mahrholdt H. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2010 Sep. 7; 56 (11): 875–887.
Review
For citations:
Namazova-Baranova L.S., Barskiy V.I., Sinitsyn V.E., Basargina E.N., Getman A.N., Sugak A.B., Silnova I.V., Arkhipova E.N., Gevorkyan A.K. MAGNETIC RESONANCE IMAGING IN DIAGNOSING FIBROTIC AND CICATRICIAL HEART ALTERATIONS IN CHILDREN. Pediatric pharmacology. 2014;11(2):78-80. https://doi.org/10.15690/pf.v11i2.962